Rhenman & Partners Asset Management Ab Exact Sciences Corp Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 465,000 shares of EXAS stock, worth $27.6 Million. This represents 2.64% of its overall portfolio holdings.

Number of Shares

465,000

Previous 145,000 220.69%

Holding current value

$27.6 Million

Previous $6.13 Million 416.83%

% of portfolio

2.64%

Previous 0.61%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $13.6 Million - $22.7 Million	320,000 Added 220.69%	465,000 $31.7 Million
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $82,660 - $148,520	2,000 Added 1.4%	145,000 $6.13 Million
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $1.24 Million - $1.62 Million	-22,000 Reduced 13.33%	143,000 $9.88 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $295,300 - $378,600	5,000 Added 3.13%	165,000 $12.2 Million
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $3.3 Million - $4.95 Million	-50,000 Reduced 23.81%	160,000 $10.9 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $2.31 Million - $3.47 Million	35,000 Added 20.0%	210,000 $14.3 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $5.33 Million - $8.08 Million	85,000 Added 94.44%	175,000 $16.4 Million
Q1 2023 May 11, 2023	SELL	$47.19 - $70.77 $943,800 - $1.42 Million	-20,000 Reduced 18.18%	90,000 $6.1 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $1.03 Million - $1.81 Million	34,000 Added 44.74%	110,000 $5.45 Million
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $1.96 Million - $2.81 Million	-34,000 Reduced 30.91%	76,000 $5.31 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $5.08 Million - $7.05 Million	-70,000 Reduced 38.89%	110,000 $8.57 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $2.26 Million - $3.1 Million	25,000 Added 16.13%	180,000 $17.2 Million
Q2 2021 Aug 13, 2021	SELL	$93.66 - $139.27 $1.87 Million - $2.79 Million	-20,000 Reduced 11.43%	155,000 $19.3 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $11.7 Million - $15.5 Million	100,000 Added 133.33%	175,000 $23.1 Million
Q4 2020 Jan 19, 2021	SELL	$99.61 - $142.12 $498,050 - $710,600	-5,000 Reduced 6.25%	75,000 $9.94 Million
Q2 2020 Jul 16, 2020	SELL	$55.75 - $92.75 $1.35 Million - $2.25 Million	-24,300 Reduced 23.3%	80,000 $6.96 Million
Q1 2020 Apr 16, 2020	SELL	$37.9 - $104.44 $102,330 - $281,988	-2,700 Reduced 2.52%	104,300 $6.05 Million
Q4 2019 Jan 17, 2020	SELL	$77.66 - $99.74 $61,040 - $78,395	-786 Reduced 0.73%	107,000 $9.9 Million
Q3 2019 Oct 16, 2019	BUY	$90.37 - $122.49 $1.61 Million - $2.18 Million	17,786 Added 19.76%	107,786 $9.74 Million
Q2 2019 Jul 22, 2019	SELL	$89.51 - $118.04 $895,100 - $1.18 Million	-10,000 Reduced 10.0%	90,000 $10.6 Million
Q1 2019 Apr 11, 2019	BUY	$61.98 - $96.5 $6.2 Million - $9.65 Million	100,000 New	100,000 $8.66 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Exact Sciences Corp Transaction History